{
    "@xmlns:dc": "http://purl.org/dc/elements/1.1/",
    "dc:title": "Genetic modification of stem cells for transplantation",
    "dc:creator": [
        "PHILLIPS, M. Ian",
        "YAO LIANG TANG"
    ],
    "dc:contributor": [
        "YE, Zhaoyang (Editor)",
        "MAHATO, Ram I (Editor)"
    ],
    "dc:relation": "Advanced drug delivery reviews -- Adv. drug deliv. rev, ISSN 0169-409X, Vol. 60 (2) , pp. 160-172",
    "dc:date": "2008",
    "dc:type": [
        "Text",
        "Article"
    ],
    "dc:language": "English",
    "dc:publisher": "Elsevier Science",
    "dc:format": [
        "print",
        "13 p. ; 10 ref"
    ],
    "dc:subject": [
        {
            "@xml:lang": "fr",
            "#text": "Cancer"
        },
        {
            "@xml:lang": "fr",
            "#text": "Cardiopathie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Endocrinopathie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Pathologie de l'appareil circulatoire"
        },
        {
            "@xml:lang": "fr",
            "#text": "Silence expression génique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Cellule souche"
        },
        {
            "@xml:lang": "fr",
            "#text": "Diabète"
        },
        {
            "@xml:lang": "fr",
            "#text": "Génétique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Insuffisance cardiaque"
        },
        {
            "@xml:lang": "fr",
            "#text": "Interférence ARN"
        },
        {
            "@xml:lang": "fr",
            "#text": "Micro ARN"
        },
        {
            "@xml:lang": "fr",
            "#text": "Technologie pharmaceutique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Tumeur maligne"
        },
        {
            "@xml:lang": "fr",
            "#text": "Vecteur"
        },
        {
            "@xml:lang": "fr",
            "#text": "Elément réponse AMP cyclique"
        },
        {
            "@xml:lang": "en",
            "#text": "Cancer"
        },
        {
            "@xml:lang": "en",
            "#text": "Heart disease"
        },
        {
            "@xml:lang": "en",
            "#text": "Endocrinopathy"
        },
        {
            "@xml:lang": "en",
            "#text": "Cardiovascular disease"
        },
        {
            "@xml:lang": "en",
            "#text": "Gene silencing"
        },
        {
            "@xml:lang": "en",
            "#text": "Stem cell"
        },
        {
            "@xml:lang": "en",
            "#text": "Diabetes mellitus"
        },
        {
            "@xml:lang": "en",
            "#text": "Genetics"
        },
        {
            "@xml:lang": "en",
            "#text": "Heart failure"
        },
        {
            "@xml:lang": "en",
            "#text": "RNA interference"
        },
        {
            "@xml:lang": "en",
            "#text": "Micro RNA"
        },
        {
            "@xml:lang": "en",
            "#text": "Pharmaceutical technology"
        },
        {
            "@xml:lang": "en",
            "#text": "Malignant tumor"
        },
        {
            "@xml:lang": "en",
            "#text": "Vector"
        },
        {
            "@xml:lang": "en",
            "#text": "Cancer"
        },
        {
            "@xml:lang": "en",
            "#text": "Cre/Lox P"
        },
        {
            "@xml:lang": "en",
            "#text": "Diabetes"
        },
        {
            "@xml:lang": "en",
            "#text": "Heart failure"
        },
        {
            "@xml:lang": "en",
            "#text": "MicroRNA"
        },
        {
            "@xml:lang": "en",
            "#text": "Neurological diseases"
        },
        {
            "@xml:lang": "en",
            "#text": "Stem cells"
        },
        {
            "@xml:lang": "en",
            "#text": "Vigilant Vector"
        },
        {
            "@xml:lang": "es",
            "#text": "Cáncer"
        },
        {
            "@xml:lang": "es",
            "#text": "Cardiopatía"
        },
        {
            "@xml:lang": "es",
            "#text": "Endocrinopatía"
        },
        {
            "@xml:lang": "es",
            "#text": "Aparato circulatorio patología"
        },
        {
            "@xml:lang": "es",
            "#text": "Silencio expresión genética"
        },
        {
            "@xml:lang": "es",
            "#text": "Célula primitiva"
        },
        {
            "@xml:lang": "es",
            "#text": "Diabetes"
        },
        {
            "@xml:lang": "es",
            "#text": "Genética"
        },
        {
            "@xml:lang": "es",
            "#text": "Insuficiencia cardíaca"
        },
        {
            "@xml:lang": "es",
            "#text": "ARN interferencia"
        },
        {
            "@xml:lang": "es",
            "#text": "Micro ARN"
        },
        {
            "@xml:lang": "es",
            "#text": "Tecnología farmacéutica"
        },
        {
            "@xml:lang": "es",
            "#text": "Tumor maligno"
        },
        {
            "@xml:lang": "es",
            "#text": "Vector"
        },
        "002B02A03: Technologie pharmaceutique. Industrie pharmaceutique / Pharmaceutical technology. Pharmaceutical industry"
    ],
    "dc:rights": [
        "Inist-CNRS",
        "Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS"
    ],
    "dc:identifier": "Inist-CNRS record number 20077040"
}